期刊文献+

心内科住院病人心脏性猝死原因分析及对策研究 被引量:1

下载PDF
导出
摘要 目的研究探讨心内科住院病人心脏性猝死原因分析及对策。方法对我院心内科2018年4月至2019年4月收治的46例心脏性猝死患者进行回顾性分析,探讨其猝死原因及对策进行分析探究。结果在基础疾病中,冠心病和高血压的发生率是比较高的,分别为28.26%(13例)、23.91%(11例),在伴随性疾病中,糖尿病的占比达到41.30%(19例),呼吸道感染的占比达到36.96%(17例),占比最小的则是急性心梗死患者,比例为6.52%(3例)。导致心脏性猝死最大的原因是情绪激动,占比达到32.61%(15例),其次是过度劳累,占比23.91%(11例),排名第三的是过度进食和抽烟,占比均为13.04%(6例)。结论心内科住院病人心脏性猝死原因较为多样,其中冠心病、高血压等基础疾病及糖尿病、呼吸道感染等伴随疾病对患者的身体情况影响较大,激动的情绪及不良生活习惯也可能会导致患者出现心脏性猝死。对此类患者的身体状态应进行密切监测,采取积极的心理干预措施,对相关诱因进行有效的控制,实现更好的预防效果。
作者 胡美林
出处 《心血管病防治知识(学术版)》 2020年第19期29-31,共3页 Prevention and Treatment of Cardiovascular Disease
  • 相关文献

参考文献7

二级参考文献32

  • 1Estes N A. The challenge of predicting and preventing sudden cardiac death immediately after myocardial infarction. Circulation, 2009,120 (3) :185 -187.
  • 2Myerburg R J. Implantable cardioverter - defibrillators after myocardial infarction. N Engl J Med,2008,359(21 ) :2245 -2253.
  • 3Passman R, Kadish A. Shouldn't everyone have an implantable cardioverter - defibrillator? Circulation, 2009,120 ( 22 ) : 2166 - 2167.
  • 4Zaman S, Sivagangabalan G, Narayan A, et al. Outcomes of early risk stratification and targeted implantable cardioverter - defibrillator implantation after ST - elevation myocardial infarction treated with primary pereutaneous coronary intervention. Circulation, 2009,120 (3) : 194 - 200.
  • 5Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter - defibrillator for congestive heart failure. N Engl J Med, 2005,352 ( 3 ) :225 - 237.
  • 6Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventrieular arrhythmia. Multicentcr Automatic Defibrillator Implanta- tion Trial Investigators. N Engl J Med, 1996,335 ( 26 ) : 1933 - 1940.
  • 7Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med ,2002,346 ( 12 ) :877 - 883.
  • 8Epstein AE, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device - Based Therapy of Cardiac Rhythm Abnormalities : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol,2008,51 (21) :1 -62.
  • 9Lim HS, Beadle R, Frenneaux M. Death and dying in heart failure with normal ejection fraction. Am J Cardiol,2009,104(9) :1311 - 1314.
  • 10Packer DL, Prutkin JM, Hellkamp AS,et al. Impact of implantable cardioverter- defibrillator, amiodarane, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Cireulatian,2009.120(22) :2170 -2176.

共引文献26

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部